Valuation: Recordati

Capitalization 9.64B 11.48B 8.81B 8.39B 15.57B 1,042B 16.2B 102B 40.55B 500B 43.08B 42.19B 1,792B P/E ratio 2025 *
21.1x
P/E ratio 2026 * 18.2x
Enterprise value 11.56B 13.76B 10.56B 10.06B 18.67B 1,250B 19.42B 123B 48.61B 600B 51.64B 50.57B 2,148B EV / Sales 2025 *
4.41x
EV / Sales 2026 * 4.06x
Free-Float
46.81%
Yield 2025 *
3.05%
Yield 2026 * 3.4%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.13%
1 week+1.73%
Current month+1.73%
1 month-4.38%
3 months-5.19%
6 months-5.19%
Current year-2.88%
More quotes
1 week 47.06
Extreme 47.06
48.4
1 month 45.9
Extreme 45.9
50.05
Current year 45.9
Extreme 45.9
50.05
1 year 43.98
Extreme 43.98
60.95
3 years 37.78
Extreme 37.78
60.95
5 years 34.52
Extreme 34.52
60.95
10 years 19.79
Extreme 19.79
60.95
More quotes
Manager TitleAgeSince
Chief Executive Officer 63 2021-11-30
Chief Tech/Sci/R&D Officer 56 2023-09-30
Compliance Officer - 2006-12-31
Director TitleAgeSince
Chairman 54 2021-11-30
Chairman 56 2018-06-11
Director/Board Member 52 2018-06-11
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.13%+1.73%-19.56%+14.25% 11.41B
-1.28%+0.73%+18.94%+206.60% 947B
-0.56%+5.01%+55.85%+45.86% 578B
-0.08%+0.11%+17.14%+54.39% 395B
-0.73%+0.88%+22.42%+23.38% 367B
-3.51%+6.69%+34.80%+10.32% 303B
-1.53%+2.12%+19.72%+29.17% 298B
+0.20%+4.87%+24.14%+49.65% 295B
+5.25%-15.84%-50.55%-35.93% 208B
-2.21%+9.93%+28.03%+56.46% 207B
Average -0.04%+2.26%+15.09%+45.42% 360.87B
Weighted average by Cap. -0.16%+2.76%+23.23%+78.46%
See all sector performances

Financials

2025 *2026 *
Net sales 2.62B 3.12B 2.39B 2.28B 4.23B 283B 4.4B 27.82B 11.01B 136B 11.7B 11.46B 487B 2.79B 3.33B 2.55B 2.43B 4.51B 302B 4.69B 29.68B 11.75B 145B 12.48B 12.22B 519B
Net income 496M 590M 453M 431M 801M 53.6B 833M 5.27B 2.09B 25.72B 2.22B 2.17B 92.13B 563M 670M 514M 489M 909M 60.82B 945M 5.98B 2.37B 29.19B 2.51B 2.46B 105B
Net Debt 1.92B 2.28B 1.75B 1.67B 3.1B 207B 3.22B 20.36B 8.06B 99.43B 8.56B 8.39B 356B 1.71B 2.03B 1.56B 1.49B 2.76B 185B 2.87B 18.14B 7.18B 88.6B 7.63B 7.47B 317B
More financial data * Estimated data
Logo Recordati
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (64.4%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (35.6%). Net sales are distributed geographically as follows: Italy (14.3%), Europe (56.1%), America (20.4%), Asia and Oceania (6.7%) and Africa (2.5%).
Employees
4,539
More about the company
Date Price Change Volume
26-02-09 47.14 -0.13% 208,463
26-02-06 47.20 -1.67% 384,988
26-02-05 48.00 -0.41% 305,733
26-02-04 48.20 +0.58% 374,119
26-02-03 47.92 +2.44% 404,413

Real-time Borsa Italiana, February 09, 2026 at 11:45 am EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
47.14EUR
Average target price
59.50EUR
Spread / Average Target
+26.22%
Consensus

Quarterly revenue - Rate of surprise